Drugs / Honghuaruyi Wan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04942015 | Jun 2021 → May 2022 | dysmenorrhea, endometriosis | Beijing University of Chinese Medicine | Unknown | Met primary |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Honghuaruyi Wan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04942015 ↗ |
| Known as | HHRY | “This study evaluates the efficacy and safety of the Tibetan herbal medication Honghua Ruyi Pill (HHRY) in managing endometriosis-related dysmenorrhea.” PMID 41529972 ↗ Dec 2025 |
| Known as | Honghua Ruyi Pill | “This study evaluates the efficacy and safety of the Tibetan herbal medication Honghua Ruyi Pill (HHRY) in managing endometriosis-related dysmenorrhea.” PMID 41529972 ↗ Dec 2025 |
| Action | Inhibit | “at the same time also can reduce the amount of TNF alpha” NCT04942015 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Honghuaruyi Wan is the traditional Tibetan prescription” NCT04942015 ↗ |
| Route | Oral | “Patients should start taking medicine with warm water” NCT04942015 ↗ |
| Target | TNF | “at the same time also can reduce the amount of TNF alpha” NCT04942015 ↗ |